Tackling the Kokoda Trail for melanoma
6 April 2018
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark “Bod” Boddison.
Fraser’s trek fell in the middle of Melanoma Institute Australia’s major fundraising and awareness campaign Melanoma March which spans across 22 locations around the country, supporting, remembering and fundraising for past and present melanoma patients.
Out of sight, does not mean out of mind for Fraser and Bod. Friends for nearly 40 years, the pair remained very close after Fraser relocated to Australia from Scotland 19 years ago. “We kept in regular contact despite being on the other side of the world. He visited me in Oz on a number of occasions and I took my family to Scotland and we spent our 40th Birthday’s together”.
Bod was diagnosed with melanoma 11 years ago but was given the all clear. Six years later, due to the viciousness of melanoma, Bod had tumours in his brain, abdomen and other parts of his body. But Bod did not lose his sense of humour or positive attitude. Fraser flew to Scotland to spend some time with his lifelong friend. “Those two weeks were priceless for us”, Fraser said.
Devastatingly, Bod lost his battle on March 11th last year. Fraser took on Kokoda just over one year since Bod passed away. Fraser is hoping to fundraise and raise awareness about melanoma. Even though Scotland doesn’t cop the brunt of extreme UV rays like Australia, melanoma doesn’t discriminate.
Bod left behind his wife Ailsa and daughter Zoe who I keep in regular contact with and they are coping as well as can be expected. I also speak regularly to Bod's parents whom I have known since I was a little schoolboy & I find it very difficult speaking to them as I can hear just how terribly sad they are without Mark.
With three young children who spend a lot of time playing outside, Fraser is patently aware of the dangers of too much sun. “I was shocked to read the statistics regarding young Aussies and melanoma so that fortified my decision to raise funds”, Fraser said.
Fraser braved harsh terrain and difficult trekking conditions including extreme humidity and wet conditions. Fraser took on an incredible challenge for Melanoma Institute Australia and you can help him take it one step further by donating to his cause here.
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina this October, to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.
The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.
We have been buoyed by the wonderful support for our Melanoma March campaign, and our mission to cover Australia in footprints continues into April!
There was a wonderful feeling of community support amongst the melanoma patients, families and friends at the WA Melanoma Community Form.
The Price family has decided to share their story to inspire Australians to support research into new melanoma treatments.
New research has provided evidence in favour of a structured skin surveillance program for high-risk melanoma patients.
Melanoma research saved Bert's life at 101 and now he wants to give back.
A new MIA online risk calculator for clinicians can determine the likelihood of thin melanoma spreading.
MIA has recently established a new division of our Clinical Trials Program which co-ordinates and manages investigator-led multi-centre trials.
Two young researchers from MIA and The University of Sydney awarded Cancer Institute NSW fellowships.
Aussies urged to leave their footprint on melanoma as efforts step up to save lives from the disease.